Case Commentary on: Zyfas Medical Co (Sued as a firm) v Millennium Pharmaceuticals, Inc [2020] SGCA 84
In the recent case of Zyfas Medical Co (Sued as a firm) v Millennium Pharmaceuticals, Inc (Zyfas), the applicant for the patent of an anti-cancer drug did not declare an existing process patent for the production of an active ingredient in the anti-cancer drug sought to be patented. According to Regulation 23(2)(a) of the […]
